跳转至内容
Merck
CN

A2795

Sigma-Aldrich

N-乙酰-d-半乳糖胺

≥98% (HPLC)

别名:

2-乙酰氨基-2-脱氧-D-半乳糖, D-GalNAc, N-乙酰半乳糖胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C8H15NO6
CAS号:
分子量:
221.21
Beilstein:
2331340
EC 号:
MDL编号:
UNSPSC代码:
12352201
PubChem化学物质编号:
NACRES:
NA.25

质量水平

检测方案

≥98% (HPLC)

形式

powder

技术

HPLC: suitable

颜色

white

mp

160 °C

溶解性

water: 50 mg/mL, clear, colorless

储存温度

2-8°C

SMILES字符串

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O

InChI

1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8?/m1/s1

InChI key

OVRNDRQMDRJTHS-KEWYIRBNSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

N-乙酰-D-半乳糖胺 (GalNAc) 是一种氨基糖,是许多 O-连接和N-连接聚糖结构的组成部分。作为尿苷二磷酸 (UDP)-GalNAc,GalNAc是许多丝氨酸和苏氨酸残基蛋白质糖基化的初始O连接糖。

应用

N-乙酰-D-半乳糖胺已用于:
  • 用作双花扁豆凝集素 (DBA) 半抗原糖,用于凝集素珠结合测定
  • 通过凝集素印迹抑制评估凝集素结合的特异性
  • 免疫组织化学预吸附紫藤凝集素

N-乙酰-D-半乳糖胺(GalNAc)是一种氨基糖,是许多O-连接和N连接聚糖结构的组分。 作为UDP-GalNAc,GalNAc是许多蛋白质糖基化丝氨酸和苏氨酸残基的起始O-连接糖。

其他说明

为了全面了解我们针对客户研究提供的各种单糖产品,建议您访问我们的碳水化合物分类页面。

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Dezemon Zingue et al.
Scientific reports, 8(1), 6778-6778 (2018-05-02)
Contaminations and fastidiousness of M. ulcerans may have both hamper isolation of strains from environmental sources. We aimed to optimize decontamination and culture of environmental samples to circumvent both limitations. Three strains of M. ulcerans cultured onto Middlebrook 7H10 at
Ju Huang et al.
Molecular therapy. Methods & clinical development, 5, 241-258 (2017-06-13)
Fabry disease is a rare lysosomal storage disorder (LSD). We designed multiple recombinant lentivirus vectors (LVs) and tested their ability to engineer expression of human α-galactosidase A (α-gal A) in transduced Fabry patient CD34
David J Gill et al.
Trends in cell biology, 21(3), 149-158 (2010-12-15)
O-GalNAc glycosylation of proteins confers essential structural, protective and signaling roles in eumetazoans. Addition of O-glycans onto proteins is an extremely complex process that regulates both sites of attachment and the types of oligosaccharides added. Twenty distinct polypeptide GalNAc-transferases (GalNAc-Ts)
Malte Lenders et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32(12), 2090-2097 (2016-09-30)
Renal and cardiac involvement is responsible for substantial morbidity and mortality in Fabry disease (FD). We analysed the incidence of FD-related renal, cardiac and neurologic end points in patients with FD on long-term enzyme replacement therapy (ERT). A retrospective analysis
Karineh Petrossian et al.
Acta histochemica, 109(6), 491-500 (2007-08-21)
By using a non-cancer and a cancer cell line originally from the same tissue (colon), coupled with testing lectins for cell binding and for their effects on these cell lines in culture, this study describes a simple multi-parameter approach that

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门